More than resveratrol: New insights into stilbene-based compounds

P Pecyna, J Wargula, M Murias, M Kucinska - Biomolecules, 2020 - mdpi.com
The concept of a scaffold concerns many aspects at different steps on the drug development
path. In medicinal chemistry, the choice of relevant “drug-likeness” scaffold is a starting point …

Application of quinoline ring in structural modification of natural products

YQ Zhao, X Li, HY Guo, QK Shen, ZS Quan, T Luan - Molecules, 2023 - mdpi.com
Natural compounds are rich in pharmacological properties that are a hot topic in
pharmaceutical research. The quinoline ring plays important roles in many biological …

Novel 1, 2, 4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies

HAM El-Sherief, BGM Youssif, SNA Bukhari… - Bioorganic …, 2018 - Elsevier
A series of novel compounds carrying 1, 2, 4-triazole scaffold was synthesized and
evaluated for their anticancer activity against a panel of cancer cell lines using MTT assay …

Discovery of novel quinoline–chalcone derivatives as potent antitumor agents with microtubule polymerization inhibitory activity

W Li, F Xu, W Shuai, H Sun, H Yao, C Ma… - Journal of medicinal …, 2018 - ACS Publications
A series of novel quinoline–chalcone derivatives were designed, synthesized, and
evaluated for their antiproliferative activity. Among them, compound 24d exhibited the most …

Development of combretastatins as potent tubulin polymerization inhibitors

SNA Bukhari, GB Kumar, HM Revankar, HL Qin - Bioorganic chemistry, 2017 - Elsevier
The combretastatins are isolated from South African tree combretum caffrum kuntze. The
lead compound combretastatin A-4 has displayed remarkable cytotoxic effect in a wide …

Potent antitumor activities and structure basis of the chiral β-lactam bridged analogue of combretastatin A-4 binding to tubulin

P Zhou, Y Liu, L Zhou, K Zhu, K Feng… - Journal of medicinal …, 2016 - ACS Publications
A series of chiral β-lactam bridged analogues (3-substituted 1, 4-diaryl-2-azetidinones) of
combretastatin A-4 (CA-4) were synthesized asymmetrically, and their antitumor activities …

An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors

H Weng, J Li, H Zhu, KF Carver Wong… - Future Medicinal …, 2023 - Taylor & Francis
Microtubules, formed by α-and β-tubulin heterodimer, are considered as a major target to
prevent the proliferation of tumor cells. Microtubule-targeted agents have become …

Copper-plumbagin complex produces potent anticancer effects by depolymerizing microtubules and inducing reactive oxygen species and DNA damage

S Mukherjee, AV Sawant, SS Prassanawar… - ACS omega, 2023 - ACS Publications
Here, we have synthesized a copper complex of plumbagin (Cu-PLN) and investigated its
antiproliferative activities in different cancer cells. The crystal structure of Cu-PLN showed …

Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents

ZS Seddigi, MS Malik, AP Saraswati, SA Ahmed… - …, 2017 - pubs.rsc.org
The dynamic and crucial role of tubulin in different cellular functions rendered it a promising
target in anticancer drug development. Combretastatin A-4 (CA-4), an inhibitor of tubulin …

Development of combretastatin A-4 analogues as potential anticancer agents with improved aqueous solubility

ZH Chen, RM Xu, GH Zheng, YZ Jin, Y Li, XY Chen… - Molecules, 2023 - mdpi.com
Combretastatin A-4 (CA-4) is a potent tubulin polymerisation inhibitor. However, the clinical
application of CA-4 is limited owing to its low aqueous solubility and the easy conversion of …